First Patient Screened for RhoVac's Clinical Phase IIb-study

Corporate Breaking News

Home : First Patient Screened for RhoVac's Clinical Phase IIb-study

Nov 04 2019	First Patient Screened for RhoVac's Clinical Phase IIb-study
STOCKHOLM, Nov. 4, 2019 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, on 4th November 2019, that the first patient has been screened for the company's clinical phase IIb study in prostate cancer, a study entitled RhoVac-002 ("BRaVac"). The screening took place at the Odense...


Source:https://www.prnewswire.com:443/news-releases/first-patient-screened-for-rhovacs-clinical-phase-iib-study-300950502.html

Related News
» Wegacha Celebrates Two Years of Success » Embed Reimagines Wearable Media that Serve to Drive Return Visits and Customer Loyalty